Eight Roads Ventures

Eight Roads Ventures is a global venture capital firm and the proprietary investment arm of Fidelity International Limited (FIL). It targets technology-enabled companies across stages from early venture to growth and late-stage, with a focus on healthcare IT, information technology, software and services, fintech, consumer and enterprise technology, telecommunications, and related sectors. It operates internationally with offices in Europe (London) and Asia (Beijing, Shanghai, Hong Kong, Tokyo, Mumbai, Bengaluru) and partnerships in Israel, Singapore, and the United States, reflecting a broad geographic scope. It typically invests between modest seven-figures to tens of millions of dollars, seeks to lead or co-lead and often takes a board seat, supporting portfolio companies with strategic and operational expertise. The firm emphasizes long-standing partnerships and a hands-on approach, backed by FIL’s resources.

Umang Agarwal

Principal

Hiroki Ashida

Vice President

Daniel Auerbach

Senior Managing Partner, Asia

Vytautas Balsys

Partner

Helena Barman

Investor

Past deals in Personal Health

Eleos Health

Series C in 2025
Eleos Health offers automated healthcare technology solutions. Its AI-powered Speech-to-Insights system aids clinicians in making decisions swiftly, ensuring personalized, efficient, and cost-effective patient care.

Spry

Series B in 2024
Spry is a digital health platform that enables movement health professionals to collect and analyze patient data in real time. By leveraging machine learning and artificial intelligence, the platform provides personalized protocols based on evidence-based practices and standards of care. This allows practitioners and owners of physical therapy centers to effectively manage both clinical and administrative functions, enhancing the quality of patient care and operational efficiency.

Pelago

Series C in 2024
Pelago specializes in virtual substance use management, empowering members to overcome addiction, primarily tobacco, alcohol, or opioids. It offers cognitive behavioral therapy (CBT) and medication-assisted treatment (MAT) programs, delivered via an accessible platform that integrates with health plans and wellness platforms.

Everheal

Venture Round in 2024
Everheal is a health technology company focused on supporting women throughout their pregnancy journey, from pre-conception to postpartum. It offers an all-in-one platform for gynecologists to enhance clinical outcomes and generate revenue through patient support features such as nutrition tracking, video consultations, automated vital sign monitoring, and an e-store.

Eleos Health

Series B in 2023
Eleos Health offers automated healthcare technology solutions. Its AI-powered Speech-to-Insights system aids clinicians in making decisions swiftly, ensuring personalized, efficient, and cost-effective patient care.

NOCD

Series B in 2023
NOCD Inc. is a Chicago-based company founded in 2014 that specializes in developing a mobile application aimed at assisting individuals with obsessive-compulsive disorder (OCD). The platform connects users to licensed therapists who specialize in OCD through face-to-face video therapy sessions. Utilizing cognitive behavioral therapy techniques, the application guides users in self-treatment and monitoring of their symptoms, offering tools for exposure and response prevention exercises. In addition to therapy sessions, NOCD provides 24/7 support via self-help resources and peer communities, facilitating ongoing care and enabling patients to manage their condition effectively. The company focuses on improving treatment outcomes for OCD through its innovative online platform.

Spry

Series A in 2022
Spry is a digital health platform that enables movement health professionals to collect and analyze patient data in real time. By leveraging machine learning and artificial intelligence, the platform provides personalized protocols based on evidence-based practices and standards of care. This allows practitioners and owners of physical therapy centers to effectively manage both clinical and administrative functions, enhancing the quality of patient care and operational efficiency.

Eleos Health

Series A in 2022
Eleos Health offers automated healthcare technology solutions. Its AI-powered Speech-to-Insights system aids clinicians in making decisions swiftly, ensuring personalized, efficient, and cost-effective patient care.

TreeENT

Series A in 2022
TreeENT Health is a specialized healthcare provider focused on ear, nose, and throat (ENT) services, established in 2017 and headquartered in Hangzhou, China. The company operates a chain of medical centers that cater to a variety of ENT conditions, including suppurative otitis media, allergic rhinitis, chronic sinusitis, and thyroid cancer. TreeENT Health utilizes advanced medical technologies, such as minimally invasive surgical techniques, internet-enabled services, and wearable medical devices, to enhance patient care. Their offerings include diagnostic services like Danish ear hearing detection, nasal endoscopy video examinations, and nasopharyngoscopy, along with personalized chronic disease rehabilitation. The integration of online appointment scheduling through platforms like WeChat facilitates convenient access to expert consultations and treatments, ensuring a high-quality experience for patients.

NOCD

Series B in 2021
NOCD Inc. is a Chicago-based company founded in 2014 that specializes in developing a mobile application aimed at assisting individuals with obsessive-compulsive disorder (OCD). The platform connects users to licensed therapists who specialize in OCD through face-to-face video therapy sessions. Utilizing cognitive behavioral therapy techniques, the application guides users in self-treatment and monitoring of their symptoms, offering tools for exposure and response prevention exercises. In addition to therapy sessions, NOCD provides 24/7 support via self-help resources and peer communities, facilitating ongoing care and enabling patients to manage their condition effectively. The company focuses on improving treatment outcomes for OCD through its innovative online platform.

Oviva

Series C in 2021
Founded in 2013, Oviva specializes in digital behavior change programs for managing type 2 diabetes and obesity. Their platform combines smartphone apps and learning portals, supported by dietitian-led coaching, enabling patients to improve their health remotely and reducing healthcare system costs.

Patient 21

Series B in 2021
Patient21 operates a health platform focused on improving the doctor-patient connection, which they view as essential for effective healthcare. The company aims to modernize the healthcare experience by addressing the fragmented and outdated processes currently prevalent in the industry. By leveraging technology, Patient21 enhances dental clinics with management software that streamlines administrative tasks such as appointment scheduling and patient data management. They also provide electronic health records (EHR) to healthcare professionals, which helps improve diagnostic quality and reduce costs. Through these innovations, Patient21 seeks to facilitate better decision-making for both patients and physicians, ultimately promoting a more personalized and collaborative approach to healthcare.

OZiva

Series B in 2021
OZiva is a plant-based clean nutrition brand that specializes in producing organic nutritional products aimed at promoting healthier lifestyle choices. The company offers a diverse range of items, including those focused on fitness, hair and skin health, and both men's and women's wellness. OZiva distinguishes itself by integrating ancient Ayurvedic principles with modern micronutrient science, creating a comprehensive nutrition and fitness ecosystem. This approach not only addresses everyday nutritional needs but also fosters a supportive digital community for individuals pursuing healthier living. Through its offerings, OZiva aims to make healthy dietary planning convenient and accessible for its customers.

Oviva

Series B in 2020
Founded in 2013, Oviva specializes in digital behavior change programs for managing type 2 diabetes and obesity. Their platform combines smartphone apps and learning portals, supported by dietitian-led coaching, enabling patients to improve their health remotely and reducing healthcare system costs.

TreeENT

Series A in 2019
TreeENT Health is a specialized healthcare provider focused on ear, nose, and throat (ENT) services, established in 2017 and headquartered in Hangzhou, China. The company operates a chain of medical centers that cater to a variety of ENT conditions, including suppurative otitis media, allergic rhinitis, chronic sinusitis, and thyroid cancer. TreeENT Health utilizes advanced medical technologies, such as minimally invasive surgical techniques, internet-enabled services, and wearable medical devices, to enhance patient care. Their offerings include diagnostic services like Danish ear hearing detection, nasal endoscopy video examinations, and nasopharyngoscopy, along with personalized chronic disease rehabilitation. The integration of online appointment scheduling through platforms like WeChat facilitates convenient access to expert consultations and treatments, ensuring a high-quality experience for patients.

Oviva

Series A in 2017
Founded in 2013, Oviva specializes in digital behavior change programs for managing type 2 diabetes and obesity. Their platform combines smartphone apps and learning portals, supported by dietitian-led coaching, enabling patients to improve their health remotely and reducing healthcare system costs.

8fit

Series A in 2017
8fit is a fitness application that aims to transform users' health and wellness journeys by offering personalized solutions. With a user base of over 20 million worldwide, the app provides custom workout plans that can be performed at home without the need for equipment, as well as tailored meal plans. By incorporating tools for weight tracking and progress monitoring, 8fit supports individuals in achieving their unique fitness goals. The company recognizes the challenges people face in their pursuit of health and emphasizes a balanced approach that prioritizes sustainable habits over quick fixes. By fostering an engaging and approachable environment, 8fit helps users navigate their paths to healthier lifestyles.

Oviva

Venture Round in 2016
Founded in 2013, Oviva specializes in digital behavior change programs for managing type 2 diabetes and obesity. Their platform combines smartphone apps and learning portals, supported by dietitian-led coaching, enabling patients to improve their health remotely and reducing healthcare system costs.

Cipla Health

Venture Round in 2016
Cipla Health is a pharmaceutical company dedicated to developing and commercializing consumer healthcare products. It specializes in creating over-the-counter medicines, including nicotine replacement therapy gum, cough lozenges, immunity booster supplements, and pregnancy care medicines. By focusing on these areas, Cipla Health aims to enhance the healthcare experience for patients and consumers alike. Its commitment to providing accessible and effective healthcare solutions underscores its role in the wellness sector.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.